The Board considered and approved the following items:
1. Fund Raising
- Approved raising funds through one or more permissible mechanisms for an amount not exceeding INR 3,000 Crore (Indian Rupees Three Thousand Crore Only) or its equivalent in any other currency.
- The fund raise may be conducted through: issuance of equity shares, debt securities, non-convertible securities, other securities including share warrants, any other equity linked securities, Qualified Institutions Placement (QIP), issuance of Depository Receipts (ADR/GDR), preferential issue on a private placement basis, rights issue, or any other permissible mode.
- The issuance may be conducted in one or more tranches, as decided by the Board.
- The fund raising is subject to approval of members and/or required statutory/regulatory approvals.
- The Board also approved certain ancillary actions for this fund raise.
2. Increase in Authorized Share Capital
- Approved increasing the authorized share capital from ₹85,00,00,000 (Rupees Eighty Five Crore Only) divided into 85,00,00,000 equity shares of Re. 1/- each to ₹100,00,00,000 (Rupees One Hundred Crore Only) divided into 100,00,00,000 equity shares of Re. 1/- each.
- This represents an increase of ₹15 crore through the creation of 15 crore new equity shares.
- Requires consequent amendment to the capital clause of the Memorandum of Association (MOA) of the Company.
- Subject to approval of members and/or required statutory/regulatory approvals.
3. Annual General Meeting
- The 29th Annual General Meeting (AGM) of the Company will be held on Wednesday, September 30, 2026.
- The AGM notice will include enabling member resolutions seeking approvals for the fund raising (item 1) and authorized capital increase (item 2).
- The copy of the AGM notice will be submitted to the stock exchanges in due course as per Listing Regulations.
Annexure Details
The annexure provides additional details as required by SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026:
- Type of securities: Equity shares, debt securities, non-convertible securities, other securities including share warrants, and any other equity linked securities
- Type of issuance: Multiple options including QIP, ADR/GDR, preferential issue, rights issue, or combinations thereof
- Total amount: Not exceeding INR 3,000 Crore (inclusive of such premium as may be fixed)
- Most other details (investor names, specific terms, pricing, etc.) are marked as "To be determined by the Board" or "Not Applicable" at this stage
This disclosure is available on the company's website (www.primefocus.com) and the stock exchange websites (BSE: www.bseindia.com, NSE: www.nseindia.com).